Sunday, April 17, 2016

One of the most interesting stories currently is the collision of sports and politics on the question of Latvian-invented meldonium. US News carries an AP story reporting that Russian President Vladimir Putin has gone on record as stating that Meldonium is not an athletic-performance-enhancing drug.

See the following link to a video at the above US News article which contains an excellent interview of Dr. Michael White, UConn School of Pharmacy, regarding meldonium, trade-named as Mildronate:

The simple fact is that a 20-capsule package of meldonium at 250 mg per capsule is an OTC (over-the-counter) medication that can be purchased without a prescription in pharmacies in Latvia (perhaps in Russia too, we do not know). Meldonium is in our view quite comparable to ubiquitous vitamin and nutritional supplements and has been available for purchase for many years.

There is no evidence that taking meldonium somehow magically "enhances" athletic performance. It may make your heart healthier, just as some vitamin or similar supplements, or even certain foods, also claim to do, but that is by no means "drug misuse" of the kind that should be prohibited in athletics.

In the interview cited above, Dr. Michael White, who otherwise gives a straightforward, very informative interview, asks why Sharapova, who spends much of her time in the USA, does not take a "comparable" USA-FDA (Food & Drug Administration) approved "heart medication" rather than meldonium. Why should she do that if she has been taking meldonium without side effects for years? Nationalistic provincialism should not mark the pharmaceutical field.

As someone who worked for years in the pharmaceutical industry, here is our very personal but we hope instructive take on a further answer to Dr. White's question about what substances we can take. It is all about money.

We are a high energy individual, so that when meldonium first came to our attention, it looked to us like an interesting alternative substance that appeared capable of strengthening the heart and had no known side effects, so we obtained meldonium as the product Mildronāts - Grindeks, perfectly legally, prescription-free, and OTC from Latvia, a European Union Member State. We have no qualms about using it in Germany, another EU Member State, which in our view can not prohibit us from using such a medication freely available in the EU, even if the substance itself may not be approved for sale in Germany itself. That would otherwise contradict the "single market" principle. We are here, after all, not dealing with some kind of illegal drug.

In our short experience we can report that meldonium seems to have a very positive effective on lowering our high blood pressure and thus far shows no negative side effects whatsoever. There may even be a positive side effect.

A package of 20 such 250mg capsules of meldonium costs about €6, so let us say ca. €10 per month if taken as we take them, at one capsule a day, even though 2 are recommended as the normal dosage. That is a cost of ca. two-thirds less than what we would have to pay out of pocket for our non-generic angiotensin II receptor blocker, since insurance covers only cheap generics -- in our experience not always comparably effective. The annual cost is thus $120 instead of $360. Quite a bit of money for an average person.

As a sample of the prices in force for a high blood pressure medication such as e.g. Micardis -- that is the brand version while the generic is called Telmisartan -- see PharmacyChecker.com, which also appends the following footnotes significant for money questions and borderline legal issues:

""*The total price includes shipping fees which typically cover an entire order....
**U.S. Law and Drug Safety: U.S. government officials have stated that individuals who order non-controlled prescription drugs from Canada or other foreign sources (up to a three-month supply) for their own use are not being pursued or prosecuted. However, it is technically not legal for individuals to import most prescription drugs. The U.S. FDA regulates the safety and efficacy of medications sold in U.S. pharmacies. Medications dispensed from outside the U.S. are regulated for safety and efficacy by pharmaceutical/pharmacy regulatory authorities in other countries. Read how regulations may differ by country.Coverage by Insurance: For a drug to be reimbursable from a health reimbursement account or flexible spending account it must be approved for sale in the U.S. and prescribed by a licensed U.S. physician, although drugs which you personally import are typically not reimbursable. If you have pharmacy insurance coverage, you may want to check with your benefits administrator to determine whether drugs ordered from outside the U.S. will be covered or reimbursed."

Why is meldonium not available for sale in Western nations? There appears to be a simple explanation. It is not a home-grown product and is priced reasonably. Hence, profits via meldonium would be much lower for indigenous pharmaceutical companies who would have to pay patent royalties on a licensed product sold much more cheaply than their own overly priced, patented, but perhaps nevertheless inferior remedies. We are reminded here of the many actions taken by Apple, Inc. to keep competing, in part, better, smartphones and tablets out of the country. The monopoly principle is the same. Keep competition out.

The meldonium controversy is thus conceivably not a medical issue at all, but rather an issue of institutional power, money and monopoly pharmaceutical markets.

The USA's FDA and similar institutions elsewhere function as "economic barriers to entry". Even if a drug has been clinically tested and approved elsewhere, every nation persists on making their own studies in determining the licensing of substances, a costly ever-duplicating process paid for by the taxpayers, who have no say in the matter, and who may even be paying top dollar for inferior pharmaceutical substances at their own local pharmacies.

When institutions such as the World Anti-Doping Agency (WADA) start blacklisting substances just because they are being used -- blacklisting without any evidence that they do in fact increase athletic performance unfairly, then things are askew in the systems of control that govern competitive sports, as we already know from negative examples at the NCAA, the FIFA and the Olympic movement. Competitive sports are dominated by self-serving monopolies, often abetted by clueless lawmakers and courts who accord such sports organizations special advantages, to which they should not be entitled at all. EVERYONE is "in business". EVERYONE.

The competitive sports world has become -- or perhaps it always has been -- a golden goose for too many organizations and their officers at the cost of the competing athletes. The private WADA is surely no exception in this regard, as its monopolistic practises have come under increasing scrutiny (see the Wikipedia for examples).

Moreover, all of these organizations try to expand their powers as much as possible so that they can tell other people what they are supposed to do. Why people have that need for power is something we have never understood.

Indeed, it is the athletes who are usually being punished by these "ruling bodies" and not those who run athletics. It is a bizarre system of top-down injustice in which the ruling organizations and institutions control the lives of athletes for their own selfish self-serving and self-sustaining ends.

And now perhaps someone in Brussels or Berlin can explain to us why in the alleged "single market" of the European Union, it is virtually impossible to order prescription-free meldonium online, as it is not delivered by Latvian pharmacies outside of the territory of Latvia, as far as we have been able to determine. Mildronate used to be available through Amazon.de. No longer. Its sale is conceivably being blocked on the orders of someone.

Moreover, we have found a few links here and there online that seem to point to meldonium "teasers" -- you are warned -- i.e. websites not actually selling meldonium but purporting to do so, and perhaps acting on behalf of other parties to discover who is taking meldonium and who is not.

Sunday, April 10, 2016

We were happy to read that the ABBYY FineReader engine has been used to preserve 4 million pages in 20 languages at the National Library of Latvia. Much material is available for public viewing.
This is not an ad, just info. See that page for further links.